Bayer Aktiengesellschaft (ETR:BAYN)
21.03
+0.08 (0.36%)
Apr 17, 2025, 5:35 PM CET
Bayer Aktiengesellschaft Revenue
In the year 2024, Bayer Aktiengesellschaft had annual revenue of 46.61B EUR, down -2.16%. Bayer Aktiengesellschaft had revenue of 11.73B in the quarter ending December 31, 2024, a decrease of -1.12%.
Revenue
46.61B
Revenue Growth
-2.16%
P/S Ratio
0.44
Revenue / Employee
514.49K
Employees
90,587
Market Cap
20.66B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 46.61B | -1.03B | -2.16% |
Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
Dec 31, 2020 | 41.40B | -2.15B | -4.93% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 22.67B |
Fresenius SE & Co. KGaA | 21.83B |
Sartorius Aktiengesellschaft | 3.44B |
Fresenius Medical Care AG | 19.34B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
SCHOTT Pharma AG & Co. KGaA | 954.68M |
Bayer Aktiengesellschaft News
- 3 days ago - Bayer CEO: targeting US state regulation to stem glyphosate costs - Reuters
- 4 days ago - Bayer Unveils $44 Million Investment in Myerstown, PA Manufacturing Facility, Renewing Commitment to U.S. Innovation, Health and Community - Business Wire
- 5 days ago - Bayer to Unveil Latest NUBEQA® (darolutamide) Data and Prostate Cancer Research at American Urological Association (AUA) 2025 Annual Meeting - Business Wire
- 6 days ago - Bayer is said to consider ending production of Roundup amid legal costs - Seeking Alpha
- 7 days ago - Farmers' Favorite Weedkiller Nears Its End, Bayer Warns - WSJ
- 7 days ago - Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing - Benzinga
- 7 days ago - EQS-PVR: Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 10 days ago - FDA Grants Complete Approval To Bayer's Drug For Certain Type Cancer With Mutation - Benzinga